Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00555555
Recruitment Status : Active, not recruiting
First Posted : November 8, 2007
Last Update Posted : March 12, 2018
Information provided by (Responsible Party):
Grifols Biologicals Inc.

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 2028
  Estimated Study Completion Date : March 2029